These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 12818628)
21. The new anticoagulants. Stone WM; Tonnessen BH; Money SR Perspect Vasc Surg Endovasc Ther; 2007 Sep; 19(3):332-5. PubMed ID: 17911567 [TBL] [Abstract][Full Text] [Related]
22. New anticoagulants. Hirsh J Am Heart J; 2001 Aug; 142(2 Suppl):S3-8. PubMed ID: 11479484 [TBL] [Abstract][Full Text] [Related]
23. Anticoagulation for acute coronary syndromes: from heparin to direct thrombin inhibitors. Lepor NE Rev Cardiovasc Med; 2007; 8 Suppl 3():S9-17. PubMed ID: 17917621 [TBL] [Abstract][Full Text] [Related]
24. New anticoagulants. Bauer KA Curr Opin Hematol; 2008 Sep; 15(5):509-15. PubMed ID: 18695376 [TBL] [Abstract][Full Text] [Related]
25. Laboratory monitoring of new anticoagulants. Castellone DD; Van Cott EM Am J Hematol; 2010 Mar; 85(3):185-7. PubMed ID: 20131309 [TBL] [Abstract][Full Text] [Related]
26. BCH-2763, a novel potent parenteral thrombin inhibitor, is an effective antithrombotic agent in rodent models of arterial and venous thrombosis--comparisons with heparin, r-hirudin, hirulog, inogatran and argatroban. Finkle CD; St Pierre A; Leblond L; Deschenes I; DiMaio J; Winocour PD Thromb Haemost; 1998 Feb; 79(2):431-8. PubMed ID: 9493603 [TBL] [Abstract][Full Text] [Related]
30. Anticoagulation beyond direct thrombin and factor Xa inhibitors: indications for targeting the intrinsic pathway? van Montfoort ML; Meijers JC Thromb Haemost; 2013 Aug; 110(2):223-32. PubMed ID: 23739841 [TBL] [Abstract][Full Text] [Related]
31. New anticoagulants: anti IIa vs anti Xa--is one better? Bauer KA J Thromb Thrombolysis; 2006 Feb; 21(1):67-72. PubMed ID: 16475045 [TBL] [Abstract][Full Text] [Related]
34. New anticoagulants for venous thromboembolic disease. Chang P IDrugs; 2004 Jan; 7(1):50-7. PubMed ID: 14730467 [TBL] [Abstract][Full Text] [Related]
35. Differential effects of direct thrombin inhibitors and antithrombin-dependent anticoagulants on the dynamics of clot formation. Young G; Yonekawa KE; Nakagawa PA; Blain RC; Lovejoy AE; Nugent DJ Blood Coagul Fibrinolysis; 2007 Mar; 18(2):97-103. PubMed ID: 17287624 [TBL] [Abstract][Full Text] [Related]
36. New anticoagulants for treatment of venous thromboembolism. Weitz JI Circulation; 2004 Aug; 110(9 Suppl 1):I19-26. PubMed ID: 15339877 [TBL] [Abstract][Full Text] [Related]
37. New trends in anticoagulant therapy. Pengo V; Pegoraro C; Iliceto S Isr Med Assoc J; 2004 Aug; 6(8):479-81. PubMed ID: 15326828 [TBL] [Abstract][Full Text] [Related]
38. [From heparin to apixaban: anticoagulants cut both ways?]. Hartung K; Meyer F; Bock F; Isermann B Zentralbl Chir; 2014 Feb; 139(1):89-97. PubMed ID: 23460104 [TBL] [Abstract][Full Text] [Related]
39. The potential role of new oral anticoagulants in the prevention and treatment of thromboembolism. Mavrakanas T; Bounameaux H Pharmacol Ther; 2011 Apr; 130(1):46-58. PubMed ID: 21185864 [TBL] [Abstract][Full Text] [Related]
40. A new era for oral anticoagulation? Old and new anticoagulant drugs. Verhamme P; Verhaeghe R Acta Cardiol; 2007 Apr; 62(2):189-98. PubMed ID: 17536609 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]